Second-Generation Antipsychotic Use in Pediatric Emergency Medicine

Area of Science:

• Pediatric Emergency Medicine
• Child and Adolescent Psychiatry
• Metabolic Disorders

Background:

• Rising mental health complaints in emergency departments.
• Increased prescription of second-generation antipsychotics (SGAs) for pediatric mental health conditions.
• Potential for SGAs to cause significant metabolic abnormalities in children.

Purpose of the Study:

• To highlight the metabolic complications associated with SGA use in children.
• To emphasize the role of pediatric emergency departments as a crucial detection point for these complications.
• To address the risks in vulnerable pediatric populations with limited access to care.

Main Methods:

• Review of clinical presentations and known side effect profiles of SGAs in pediatric populations.
• Analysis of the potential for early detection within the emergency department setting.
• Focus on identifying components of metabolic syndrome and type 2 diabetes.

Main Results:

• Children on SGAs are at risk for rapid weight gain, central adiposity, glucose intolerance, dyslipidemia, and hypertension.
• These metabolic abnormalities can manifest as metabolic syndrome or type 2 diabetes.
• Increased risk for long-term cardiovascular complications is associated with these conditions.

Conclusions:

• Pediatric emergency departments serve as a critical safety net for identifying SGA-related metabolic complications.
• Early detection is vital, particularly for children without consistent access to primary or psychiatric care.
• Prompt identification can mitigate the risk of severe cardiovascular outcomes later in life.